#executive moves

All articles tagged with "executive moves"

Boehringer appoints pharma veteran for corporate affairs post; BlueRock CSO heads for the exit

Boehringer and BlueRock Update Leadership Ranks in a Quiet but Telling Biopharma Reshuffle

Boehringer Ingelheim has named Christie Bloomquist to a senior US human pharma and foundation role, while BlueRock Therapeutics is seeing the departure of its chief scientific officer.

Key Takeaways

Boehringer Ingelheim named Christie Bloomquist as SVP of corporate affairs for US human pharma.
Bloomquist will also serve as president of the Boehringer Cares Foundation.

DT Editorial Team·May 3, 2026·via endpoints.news

Amgen CTO David Reese to Retire at End of June

Amgen says longtime executive David Reese, who currently serves as chief technology officer, will retire at the end of June, marking a leadership change inside one of biotech’s largest companies.

Key Takeaways

Amgen says chief technology officer David Reese will retire at the end of June.
Endpoints reports Reese is a longtime Amgen leader and is 63.

DT Editorial Team·Apr 23, 2026·via endpoints.news

Pharma’s Latest People Moves Show How Closely the Industry Tracks Leadership Change

STAT+ has published its latest roundup of hires, departures, promotions, and transfers across pharma and biotech, underscoring how personnel changes remain a closely watched signal inside the industry.

Key Takeaways

STAT+ published a new roundup of hires, departures, promotions, and transfers in pharma and biotech.
The supplied source text supports the item as an industry personnel tracker rather than a single-company report.

DT Editorial Team·Apr 11, 2026·via statnews.com